We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

IonGate Biosciences and LIVC Technologies Establish Technology and Marketing Co-operation

News   Sep 05, 2007

 
IonGate Biosciences and LIVC Technologies Establish Technology and Marketing Co-operation
 
 
 

RELATED ARTICLES

Designer Drugs to Inhibit Hepatitis A Virus

News

Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection.

READ MORE

Triple-negative Breast Cancers Can Adopt Reversible State That is Resistant to Chemotherapy

News

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

READ MORE

Combining CRISPR With Drug Discovery to Understand Treatment Efficacy

News

Researchers combine CRISPR gene-editing technology with drug discovery to understand why treatment works (or doesn’t).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE